Asked | Open questions | Answered
Points Date Pair Term / Answer given Level Status Gloss
- Mar 14 '22 eng>fra Agitation/Restlessness agitation/impatience easy closed ok
4 Feb 27 '22 eng>fra research study Étude de recherche pro closed ok
4 Feb 14 '22 eng>fra labelled dose dose autorisée pro closed ok
4 Feb 14 '22 eng>fra MOD/MOA mécanisme de la maladie (MoD)/mécanisme d'action (MoA) easy closed ok
4 Feb 10 '22 eng>fra eGFR kidney composite outcome résultat composite rénal DFGe pro closed ok
4 Feb 10 '22 eng>fra a matched population une population appariée pro closed ok
- Feb 8 '22 eng>fra absence of unobserved confounding variables absence de variables confusionnelles non observées pro closed no
4 Feb 7 '22 eng>fra population-adjusted indirect treatment comparison Comparaison indirecte de traitement ajustée à la population pro closed ok
4 Dec 20 '21 eng>fra read-through translecture pro closed ok
4 Nov 23 '21 eng>fra caking and clumping mottage et agglutination easy closed ok
- Nov 8 '21 eng>fra CVA Analyse de Capacité et de Vulnérabilité pro just_closed no
- Sep 21 '21 eng>fra Prescribing Information renseignements posologiques pro closed ok
4 Sep 21 '21 eng>fra Risk Minimisation Materials Mesures additionnelles de réduction du risque (MARR) pro closed ok
4 Sep 17 '21 eng>fra to shift the paradigm changer le paradigme du traitement pro closed ok
4 Sep 13 '21 eng>fra preponderance of the system in nonimmunogenicity prépondérance du système en matière de non-immunogénicité pro closed ok
4 Sep 11 '21 eng>fra When the GvHD occurred La maladie du greffon contre l'hôte pro closed ok
4 Apr 15 '21 eng>fra rescue inhaler inhalateurs de secours pro closed ok
- Mar 16 '21 eng>fra no changes in other items pas de changement dans les autres paramètres pro closed ok
4 Mar 11 '21 eng>fra mechanistic (sub-study) sous-étude mécanistique pro closed ok
4 Mar 8 '21 eng>fra gross necropsy findings résultats d'autopsie grossière pro closed ok
4 Feb 12 '21 eng>fra Approved Product Information information produit approuvée pro closed ok
4 Feb 2 '21 eng>fra efficacy horizon L’efficacité à long terme n’est pas clairement établie pro closed ok
- Jan 23 '21 eng>fra at last sample time point au dernier point expérimental easy closed ok
4 Jan 18 '21 eng>fra ADE rate taux de renforcement dépendant des anticorps (ADE) pro closed ok
- Dec 24 '20 eng>fra of nominal significance only de seule (ne concerne que la) significativité nominale pro closed ok
- Dec 21 '20 eng>fra associated with severely impaired survival associée à une forte réduction de l'espérance de vie easy closed ok
- Dec 20 '20 eng>fra landmark trial étude emblématique pro closed ok
- Dec 20 '20 eng>fra Loss of fluid control perte du contrôle des fluides corporels pro closed ok
4 Dec 19 '20 eng>fra Win ratio win ratio pro closed ok
- Dec 17 '20 eng>fra titrated background therapy traitement de fond par titration de la dose pro closed ok
4 Nov 24 '20 eng>fra All comers population globale pro closed ok
4 Nov 24 '20 eng>fra NIH Formula A ACD-A pro closed ok
- Nov 16 '20 eng>fra to reduce patient loss pour réduire la perte de patients pro closed ok
- Nov 7 '20 eng>fra CONTRACT MANUFACTURING SITES site de production/fabrication easy closed ok
4 Nov 6 '20 eng>fra investigation of the dose recherche de la dose pro closed ok
4 Nov 6 '20 eng>fra rolling New Drug Application (NDA) approbation d'un nouveau médicament pro closed ok
4 Oct 27 '20 eng>fra treat-through study traitement continu pro closed ok
- Oct 7 '20 eng>fra Test entry à l'inclusion pro open no
4 Oct 7 '20 eng>fra risk set sampling stratégie d'échantillonnage axée sur les risques pro closed no
- Oct 7 '20 eng>fra single-agent comme agent unique pro closed ok
- Sep 30 '20 eng>fra in the 1st-line maintenance setting Traitement de maintien de première ligne pro closed ok
4 Sep 30 '20 eng>fra in the 1st-line maintenance setting Traitement de maintien de première ligne pro closed ok
4 Sep 10 '20 eng>fra not at goal N’atteignant pas l’objectif thérapeutique de easy closed ok
4 Aug 27 '20 eng>fra PDC PJC pro closed ok
4 Aug 26 '20 eng>fra spinal pain, backpain and nocturnal backpain douleur rachidienne, dorsalgie/douleur dorsale et douleurs dorsales nocturnes pro closed ok
4 Jul 8 '20 eng>fra fallback methode de repli pro closed ok
4 Jul 5 '20 eng>fra DM and sex by region by DM interaction diabète et sex par région, par interaction avec le diabète pro closed ok
4 Jul 4 '20 eng>fra The IGF-I standard deviation score target cible score de déviation standard d'Igf-1 pro closed ok
4 May 3 '20 eng>fra could blunt the vaccine's effectivenesss atténuer l'efficacité du vaccin pro closed ok
4 Mar 30 '20 eng>fra first-in-class inhibitor inhibiteur "first in class" pro closed ok
Asked | Open questions | Answered